Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2012

Dec 14, 2012

30198_dirs_2012-12-14_d0495da2-8a8a-4453-81a5-919201cfbbad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2012-12-12

Reporting Person: VALDES JORGE A (CTO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-12 Common Stock S 4122 $14.2923 Disposed 27750 Indirect
2012-12-13 Common Stock S 4811 $14.1 Disposed 22939 Indirect
2012-12-13 Common Stock S 22939 $14 Disposed 0 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 153323 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $14.29 to $14.30. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F2: Shares are held by Jorge A. Valdes and Suzanne Lopez-Calleja, Joint Tenants.